Pharma Compliance Europe 2017

Topics

• Global anti bribery and corruption developments review
• Regional transparency, disclosure and aggregate spend requirements
• Product promotional compliance
• Third party intermediaries: due diligence and monitoring considerations
• Operational compliance best practices
• Compliant communication with customers of today and tomorrow

Who should Attend

Major medical device, pharmaceutical and regulatory agencies.